Blue Sail (China) Performance
002382 Stock | 4.76 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0674, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Blue Sail's returns are expected to increase less than the market. However, during the bear market, the loss of holding Blue Sail is expected to be smaller as well. At this point, Blue Sail Medical has a negative expected return of -0.17%. Please make sure to confirm Blue Sail's information ratio, total risk alpha, potential upside, as well as the relationship between the jensen alpha and treynor ratio , to decide if Blue Sail Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Blue Sail Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Last Split Factor 20:10 | Ex Dividend Date 2023-05-31 | Last Split Date 2016-05-17 |
Begin Period Cash Flow | 1.9 B |
Blue |
Blue Sail Relative Risk vs. Return Landscape
If you would invest 534.00 in Blue Sail Medical on November 2, 2024 and sell it today you would lose (58.00) from holding Blue Sail Medical or give up 10.86% of portfolio value over 90 days. Blue Sail Medical is generating negative expected returns and assumes 1.6925% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Blue, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Blue Sail Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Blue Sail's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Blue Sail Medical, and traders can use it to determine the average amount a Blue Sail's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1029
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 002382 |
Estimated Market Risk
1.69 actual daily | 15 85% of assets are more volatile |
Expected Return
-0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Blue Sail is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Blue Sail by adding Blue Sail to a well-diversified portfolio.
Blue Sail Fundamentals Growth
Blue Stock prices reflect investors' perceptions of the future prospects and financial health of Blue Sail, and Blue Sail fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Blue Stock performance.
Return On Equity | -0.0442 | ||||
Return On Asset | -0.0129 | ||||
Profit Margin | (0.07) % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 6.24 B | ||||
Shares Outstanding | 1.01 B | ||||
Price To Book | 0.54 X | ||||
Price To Sales | 0.80 X | ||||
Revenue | 4.93 B | ||||
Gross Profit | 857.27 M | ||||
EBITDA | 198.28 M | ||||
Net Income | (568.36 M) | ||||
Total Debt | 3.86 B | ||||
Book Value Per Share | 8.82 X | ||||
Cash Flow From Operations | (72.89 M) | ||||
Earnings Per Share | (0.44) X | ||||
Total Asset | 15.63 B | ||||
Retained Earnings | 2.12 B | ||||
About Blue Sail Performance
By analyzing Blue Sail's fundamental ratios, stakeholders can gain valuable insights into Blue Sail's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Blue Sail has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Blue Sail has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Blue Sail is entity of China. It is traded as Stock on SHE exchange.Things to note about Blue Sail Medical performance evaluation
Checking the ongoing alerts about Blue Sail for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Blue Sail Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Blue Sail Medical generated a negative expected return over the last 90 days | |
Blue Sail Medical has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 4.93 B. Net Loss for the year was (568.36 M) with profit before overhead, payroll, taxes, and interest of 857.27 M. | |
Blue Sail generates negative cash flow from operations | |
About 33.0% of the company shares are owned by insiders or employees |
- Analyzing Blue Sail's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Blue Sail's stock is overvalued or undervalued compared to its peers.
- Examining Blue Sail's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Blue Sail's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Blue Sail's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Blue Sail's stock. These opinions can provide insight into Blue Sail's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Blue Stock analysis
When running Blue Sail's price analysis, check to measure Blue Sail's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blue Sail is operating at the current time. Most of Blue Sail's value examination focuses on studying past and present price action to predict the probability of Blue Sail's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blue Sail's price. Additionally, you may evaluate how the addition of Blue Sail to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies |